Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.500
-0.090 (-5.66%)
At close: Nov 19, 2026, 4:00 PM EST
1.450
-0.050 (-3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year. That makes Elicio Therapeutics the 36,798th largest employer in the world and 5,060th in the United States.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,082,939
Market Cap
42.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| MindWalk Holdings | 77 |
| Pliant Therapeutics | 49 |
| Mereo BioPharma Group | 39 |
| IRulya Therapeutics | 38 |
| Actinium Pharmaceuticals | 27 |
| ImageneBio | 18 |
| Apollomics | 14 |
ELTX News
- 8 days ago - Elicio Therapeutics Transcript: KOL event - Transcripts
- 9 days ago - Elicio Therapeutics price target lowered to $21 from $23 at H.C. Wainwright - TheFly
- 14 days ago - Elicio Therapeutics reports Q3 EPS (30c), consensus (43c) - TheFly
- 14 days ago - Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 14 days ago - Elicio Therapeutics Quarterly report: Q3 2026 - Filings
- 14 days ago - Elicio Therapeutics Earnings release: Q3 2026 - Filings
- 15 days ago - Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC - GlobeNewsWire
- 21 days ago - Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at the SITC 2026 Annual Meeting - GlobeNewsWire